New data reveals out-of-hospital cardiac survival results remain low in England
In 2022, around 8% of patients survived 30 days after a cardiac arrest
Read More
Tag: University of Warwick Clinical Trials Unit
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
- Gedeon Richter UK takes over UK rights to cariprazine
- Otsuka Pharmaceutical’s Dawnzera receives EC approval for hereditary angioedema prevention
